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ABSTRACT
Sarcoidosis is a multisystem inflammatory disease of un-
known etiology. The lungs and the lymphoid system are the 
most commonly involved organs. Extrapulmonary involve-
ment is reported in 30% of patients, and the abdomen is 
the most common extrapulmonary site with a frequency of 
50%–70%. 
Although intra-abdominal sarcoidosis is usually asymptom-
atic, its presence may affect the prognosis and treatment 
options. The lesions are less characteristic and may mimick 
neoplastic or infectious diseases such as lymphoma, diffuse 
metastasis, and granulomatous inflammation. The liver and 
spleen are the most common abdominal sites of involve-
ment. Sarcoidosis of the gastrointestinal system, pancreas, 
and kidneys are extremely rare. Adenopathy which is most 
commonly found in the porta hepatis, exudative ascites, and 
multiple granulomatous nodules studding the peritoneum 
are the reported manifestations of abdominal sarcoidosis.
Since abdominal sarcoidosis is less common and long-stand-
ing, unrecognized disease can result in significant morbidity 
and mortality. Imaging contributes to diagnosis and man-
agement of intra-abdominal sarcoidosis. In this report we re-
viewed the cross-sectional imaging findings of hepatobiliary, 
gastrointestinal, and genitourinary sarcoidosis.
S arcoidosis is a multisystemic inflammatory disease of unknown etiology. It is characterized by noncaseating epithelioid cell gran-ulomas in the absence of other granulomatous diseases such as 
tuberculosis, fungal infections, autoimmune processes, or delayed-type 
hypersensitivity reaction to foreign antigens (1). Epidemiology of the 
disease varies among racial groups. The global prevalence is reported to 
be 2–60 per 100,000 people (2). Higher rates are detected in people of 
Scandinavian and Irish descent (2). 
Sarcoidosis is usually diagnosed between 20 and 40 years of age (3). 
Women are more frequently affected than men (3). The etiology of the 
disease is still not exactly clarified. The lungs and the lymphoid system 
are the most commonly involved sites with a frequency of 90% and 
30%, respectively (4). Extrapulmonary involvement of sarcoidosis is re-
ported in 30% of patients and the abdomen is the most common extra-
thoracic site with a frequency of 50%–70%. Liver (50%–80%), spleen 
(40%–80%), lymph nodes (30%), and kidney are frequently involved 
abdominal sites, sometimes without symptoms. Cardiopulmonary in-
volvement is the main cause of death.
Diagnosis of sarcoidosis is based upon clinical features and demon-
stration of noncaseating granulomas in at least two different organs. A 
negative staining and culture for acid fast bacilli, exclusion of drug-in-
duced disease and exposure to toxins are also included in the diagnostic 
criteria. The overall prognosis is good, although most patients would 
have permanent organ impairment. Corticosteroids and steroid-sparing 
agents such as methotrexate, azathioprine, and anti-TNF-α are institut-
ed for immunosuppressive treatment when major organs are involved 
or organ function is threatened. 
Abdominal sarcoidosis can occur in the absence of lymphatic or pul-
monary disease (4). Although usually asymptomatic, the presence of 
symptomatic abdominal involvement may affect the prognosis and 
treatment options. Symptomatic abdominal sarcoidosis requires treat-
ment with immunosuppressant agents. Surgical interventions may be 
required in the presence of gastrointestinal complications such as mas-
sive hemorrhage, strictures, obstruction, or perforation. Splenectomy 
can be performed for symptomatic relief in splenic involvement or as 
prophylaxis for splenic rupture. 
The lesions in abdominal sarcoidosis are less characteristic, mimicking 
more common neoplastic or infectious diseases such as lymphoma, dif-
fuse metastasis, granulomatous or mycobacterial infections (5). Further-
more, it is reported that a significant fraction (26%) of subjects may have 
hepatic sarcoidosis without pulmonary involvement (6). In this article 
we aimed to review the imaging manifestations of abdominal sarcoidosis.
From the Department of Radiology (N.S.G.  drsinemgezer@
gmail.com, I.B., C.A., M.S.), School of Medicine, Dokuz Eylul 
University, Izmir, Turkey; the Department of Radiology (M.H.), 
School of Medicine, Ege University, Izmir, Turkey; the Department 
of Pathology (L.R.), Centre Hospitalier Paris Sud, Paris, France; the 
Department of Radiology (N.K.),  School of Medicine, Pamukkale 
University, Denizli, Turkey.
Received 1 June 2014, revision requested 29 June 2014, final revision 
received 19 August 2014, accepted 19 August 2014.
Published online 11 December 2014.
DOI 10.5152/dir.2014.14210
111
112 • March–April 2015 • Diagnostic and Interventional Radiology Gezer et al.
Liver and biliary tract
Hepatic involvement of sarcoidosis 
follows lymph nodes and lung in fre-
quency. It has been reported in 50%–
79% of patients by biopsy, and 67%–
70% in autopsy series (7). Despite this 
common hepatic involvement, the fre-
quency of liver function test abnormal-
ities is about 35% (8). Liver biopsy is the 
only way to make a definitive diagnosis 
of hepatic involvement (4). Less than 
5% of patients with sarcoidosis suffer 
from symptomatic liver disease.
Hepatomegaly is the most common 
imaging finding of hepatic sarcoidosis, 
detected on computed tomography 
(CT) of the abdomen in about more 
than half of the patients (9). It is often 
associated with splenomegaly. Other 
findings range from asymptomatic in-
cidental granulomas becoming more 
confluent with increasing size, to por-
tal hypertension and cirrhosis because 
of chronic inflammation, granuloma 
formation, and fibrosis in the portal 
triads. Focal nodules are seen in the 
range of 0%–19% (10–12). Another 
frequent complication of hepatic sar-
coidosis is the portal vein thrombosis 
as a result of stasis from obliterated 
small portal veins (13). It has also been 
proposed that there is a correlation be-
tween chronic hepatic sarcoidosis and 
hepatocellular carcinoma (14). 
Granulomatous inflammation of the 
gallbladder or extrinsic compression 
of the cystic duct by enlarged lymph 
nodes may lead to acute cholecystitis 
(15). Subacute or chronic cholecystitis 
due to granulomas in the gallbladder 
wall has also been reported as a compli-
cation of biliary sarcoidosis (16). Gran-
ulomatous involvement of the com-
mon hepatic duct and accompanying 
enlarged granulomatous lymph nodes 
are reported leading to obstructive 
jaundice (17). Sarcoidosis may cause 
strictures in extrahepatic bile ducts 
mimicking cholangiocarcinoma. Sever-
al case series have implied that, there is 
an association between sarcoidosis and 
sclerosing cholangitis (18).
Ultrasonography (US) findings of 
hepatic sarcoidosis include increased 
parenchymal echogenicity and coars-
ening of the parenchymal appear-
ance with or without discrete nodules 
(Fig. 1) (19). Calcification can rarely 
be seen if the disease is long-standing 
(19). The nodules which represent the 
coalescence of small granulomas are 
typically innumerable, diffusely distrib-
uted, and range from 1–2 mm to several 
centimeters in size. They have been re-
ported to be hypoechoic on US and hy-
podense on CT scans, relative to the liv-
er parenchyma (Fig. 2) (19). However, 
they may also be hyperechoic depend-
ing on background liver echogenicity 
and the degree of fibrosis present in the 
granuloma. Because of these nonspecif-
ic imaging findings, tissue biopsy may 
be necessary to differentiate hepatic sar-
coidosis from metastases and lympho-
ma (20). Focal nodules are identified in 
5% of patients at imaging examinations 
(Fig. 3) (21). Contour irregularity can 
also be seen in sarcoidosis (Fig. 4) (19).
On MRI, nodular lesions of 5–20 mm 
are characteristically hypointense on 
all sequences which are most apparent 
on the T2-weighted fat-saturated im-
ages (Fig. 5a) (22). This finding helps 
excluding metastases and inflamma-
tory diseases which are usually hyper-
intense on T2-weighted fat-saturated 
images. They enhance less than the 
background liver on gadolinium-en-
hanced T1-weighted images (Fig. 5b) 
(22). Contour irregularity of the liver 
Figure 1. Axial US image of a 59-year-
old female with biopsy-proven hepatic 
sarcoidosis demonstrates innumerable, 
diffusely distributed hypoechoic granulomas 
(dashed arrows) in an enlarged hyperechoic 
liver. A periportal hypoechoic enlarged lymph 
node (arrows) is also detected at the hilum of 
the liver.
Figure 2. Axial contrast-enhanced CT image 
of a 23-year-old female with biopsy-proven 
hepatosplenic sarcoidosis shows coalescence 
of granulomas in the form of large, 
geographic, hypoechoic, hypodense areas in 
an enlarged liver and the spleen. 
Figure 3. Liver US of a 52-year-old female 
demonstrates three hypoechoic nodules 
(arrows) in the right lobe of the liver 
representing noncaseating granulomas 
proven by biopsy.
Figure 4. a, b. A 41-year-old female with biopsy-proven hepatosplenic sarcoidosis. Contrast-
enhanced axial CT image (a) and follow-up CT examination after three years (b). Contour 
irregularity of the shrinking liver became prominent within three years (b, arrows).
a b
and high periportal signal intensity are 
the other reported MRI findings of he-
patic sarcoidosis (19).
Spleen
Splenic involvement has been re-
ported in 24%–53% of cases (23). Sple-
nomegaly due to sarcoidosis is com-
monly associated with involvement 
of the lungs and the liver. Splenic in-
filtration can be homogeneous or in 
the form of multiple discrete nodules 
(24, 25). Splenic nodules can be seen 
in 15% of the abdominal CT scans and 
are more common than the hepatic 
nodules (21). The differential diagno-
sis of hypodense nodules in both liver 
and spleen includes tuberculosis, lym-
phoma, metastasis, and abscess. Infec-
tions such as candidiasis should also 
be considered if the patient is immu-
nocompromised.
Similar to hepatic nodules, the 
splenic nodules are seen as multiple, 
hypoechoic, hypodense, hypointense, 
and nonenhancing lesions, scattered 
in the spleen (Figs. 6, 7a). They tend to 
be discrete, but may coalesce as they 
increase in size (22). Contour irregu-
larity is another abnormal finding of 
splenic sarcoidosis (Fig. 7b) (19). 
Gastrointestinal tract
Gastrointestinal (GI) tract involve-
ment in sarcoidosis is extremely rare 
and the majority of the cases are as-
ymptomatic. On autopsy series, about 
10% of patients with systemic sarcoid-
osis were found to have gastric gran-
ulomatous mucosal infiltration, most 
commonly in the antrum (26). Dif-
ferential diagnosis of gastrointestinal 
sarcoidosis includes Crohn’s disease, 
malignancies, gastritis, and infectious 
diseases such as tuberculosis and fun-
gal infections, and a definitive diagno-
sis requires biopsy (26).
Gastric involvement in sarcoidosis 
can be localized or diffuse. In the local-
ized form, granulomatous infiltration of 
the mucosa leading to ulcer formation, 
gastritis, hyperemia with friable muco-
sa, or nodular irregularities resembling 
polyps are seen (4). In diffuse form, 
fibrosis due to granulomatous infiltra-
tion, widespread mucosal thickening, 
rigidity, and reduction in lumen size 
have been reported (26–28). Antral nar-
rowing and deformity owing to gastric 
mucosal fold enlargement may lead to 
gastric outlet obstruction mimicking 
Menetrier’s disease (29, 30). The most 
common imaging finding of upper GI 
involvement is a segmental linitis plasti-
ca-type appearance which should be dif-
ferentiated from gastric carcinoma (29). 
Extrinsic compression from extensively 
enlarged retroperitoneal lymph nodes 
may also occur throughout the GI tract. 
Small bowel is the least common site 
of involvement in GI sarcoidosis (27). 
Reported manifestations of intestinal 
sarcoidosis include intestinal obstruc-
tion due to extrinsic compression by 
enlarged mesenteric and abdominal 
lymph nodes or reduction of the lu-
men size secondary to cicatrizing con-
striction of mucosal granulomatous 
lesions (Fig. 8) (4, 31). Differential 
diagnosis of small bowel sarcoidosis 
includes Crohn’s disease, carcinoma, 
foreign body reactions, intestinal tu-
berculosis, Whipple’s disease, and 
celiac disease. Elevated angiotensin 
converting enzyme levels, superficial 
mucosal involvement instead of trans-
mural inflammation, absence of peri-
anal disease, fistulas, or strictures may 
favor the diagnosis of sarcoidosis (32).
Sigmoid colon is the most frequently 
involved site of large bowel (27). Col-
orectal sarcoidosis can occur despite the 
presence of a grossly normal appear-
ing mucosa. Multiple nodules, polyps, 
aphthous erosions, ulcers, obstructive 
lesions, or stenosis are the imaging 
findings of manifest colonic sarcoidosis 
(Fig. 8) (33–36). External compression by 
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Figure 5. a, b. A 50-year-old female with biopsy-proven hepatosplenic sarcoidosis. T2-
weighted fat-saturated images show hypointense lesions in the liver and spleen (a). The lesions 
enhance less than the background liver on gadolinium-enhanced T1-weighted images (b). 
a b
Figure 6. Sagittal US image of a 59-year-old 
female with proven splenic sarcoidosis shows 
a 3.5 cm hypoechoic, focal lesion (arrow) in 
an enlarged spleen, due to a noncaseating 
granuloma.
Figure 7. a, b. A 45-year-old female with proven splenic sarcoidosis. Contrast-enhanced CT of 
the abdomen shows multiple hypodense granulomas infiltrating the enlarged spleen (a). Contour 
irregularity of the shrinking spleen became prominent within six-years follow-up (b, arrows).
a b
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enlarged lymph nodes is the most com-
mon reason of intestinal obstruction.
Sarcoidosis has been reported to 
be one of the causes of noninfec-
tious granulomatous appendicitis, 
along with foreign body reaction and 
Crohn’s disease. A markedly enlarged, 
unopacified appendix of soft tissue 
density, larger than that is seen in 
“simple acute appendicitis” and in-
distinguishable walls may be the find-
ings on CT (Fig. 9). The absence of fat 
stranding or periappendiceal fluid and 
the presence of enlarged lymph nodes 
in a subject with distended appendix 
should alert radiologists for the possi-
bility of a granulomatous appendicitis, 
carcinoma, or lymphoma (37).
Peritoneum and lymph nodes
Peritoneal involvement is extremely 
rare in sarcoidosis (38, 39). The most 
frequent clinical presentations of peri-
toneal sarcoidosis are exudative ascites, 
multiple granulomatous nodules stud-
ding the peritoneum, or a single peri-
toneal lesion (Fig. 8). Peritoneal biopsy 
is required to rule out carcinomatosis, 
tuberculosis, and fungal infections (4, 
31). Symptoms usually regress without 
any treatment or with short-term treat-
ment of corticosteroids (39).
Enlarged lymph nodes are detected 
in approximately 30% of patients par-
ticularly in the porta hepatis, para-aor-
tic region, and the celiac axis (9, 21). 
Unlike lymphoma, the lymph nodes 
are tpically smaller than 2 cm in diam-
eter and more discrete rather than con-
fluent. Compared to lymphoma, in-
volvement of the retrocrural area is less 
common (9). Affected lymph nodes 
show soft tissue attenuation on CT 
Figure 8. a–c. Barium small bowel follow-through (a) shows mucosal irregularity, nodularity, and angulation of terminal ileum and ileocecal region 
(arrow) in a 62-year-old female patient with biopsy-proven sarcoidosis. Subsequent contrast-enhanced CT examination (b) demonstrates multiple 
lymph nodes in the mesenteric root (arrows). Panel (c) shows wall thickening of the caecum (dashed arrow), heterogeneous hyperdensity of the 
omentum (arrows) and mesenteric free fluid (open arrows).
a b
c
Figure 9. a–c. Contrast-enhanced abdominal CT of a 38-year-old male suffering from cough and abdominal pain. Enlarged lymph nodes in the 
mesenteric root (a, arrows), a markedly enlarged appendix with thickening of the wall (b, c, arrows) and thickening of the caecal apex (c, open 
arrow) are seen. Bronchoscopic and colonoscopic biopsies revealed chronic granulomatous inflammation confirming the diagnosis of pulmonary 
and gastrointestinal sarcoidosis.
a b c
Figure 10. a, b. A 62-year-old female with biopsy-proven abdominal sarcoidosis. Contrast-
enhanced CT of the abdomen shows peripancreatic (a) and pericecal (b) enlarged hypodense 
lymph nodes with peripheral and heterogeneous enhancement.
a b
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(Fig. 10). They appear homogenously 
hyperintense or may resemble central 
hypointensity surrounded by peripher-
al high signal intensity on T2-weight-
ed fat-saturated images. They are mild-
ly enhanced on gadolinium-enhanced 
T1-weighted images (Fig. 11) (40).
Pancreas
Pancreatic sarcoidosis has been de-
tected in 1%–3% of cases with systemic 
disease on autopsy series. It may lead 
to symptoms such as abdominal pain, 
nausea and vomiting, weight loss, 
and obstructive jaundice; however, it 
is rarely symptomatic during life (41). 
Sarcoidosis of pancreas may be in the 
form of direct tissue infiltration, duct 
obstruction, or constrictive peripancre-
atic lymphadenopathy. Tissue infiltra-
tion has been reported to be diffusely 
nodular in about half of the cases (42). 
In the other half, a focal pancreatic 
mass is seen usually in the head of the 
pancreas; this mass mimics pancreatic 
cancer and requires surgical resection 
for differential diagnosis (Fig. 12) (42). 
However, cholangiograms typically 
show a long, smoothly tapered narrow-
ing rather than the more abrupt termi-
nation associated with tumor (43).
On CT scans, pancreatic sarcoidosis 
manifests as solitary ill-defined pan-
creatic masses, dilatation of the com-
mon bile duct and pancreatic duct, or 
peripancreatic lymphadenopathy. On 
MRI, T1-weighted images show multi-
ple hypointense masses, T2-weighted 
images show mildly elevated signal 
intensity, and gadolinium-based intra-
venous contrast administration shows 
reduced enhancement compared to 
normal pancreas (44).
Kidney
Nephrocalcinosis, nephrolithiasis, 
and interstitial calcium deposition 
which may lead to renal failure have 
been reported in sarcoidosis. Intersti-
tial nephritis is a possible manifesta-
tion, and may demonstrate a striated 
nephrogram on contrast-enhanced 
CT (45). The most frequently detected 
effect of sarcoidosis on the kidney is 
nephrocalcinosis. It results from hyper-
calcemia and hypercalciuria secondary 
to production of calcitriol typically by 
the extrarenal granulomata (20, 46). 
In the presence of nephrocalcinosis, 
corticosteroids are used in addition 
to management of hypercalcemia and 
hypercalciuria. 
Direct granulomatous involvement 
of the kidneys is rarely observed; how-
ever, it is indistinguishable from lym-
phoma or metastasis (47). Glomeru-
lar nephritis from direct infiltration 
may also occur, although it usually 
does not impair renal function (46). 
Figure 11. A 58-year-old female with biopsy-
proven abdominal sarcoidosis. Gadolinium-
enhanced T1-weighted image shows enlarged 
and discrete lymph nodes smaller than 2 cm 
in diameter detected in the porta hepatis, 
peripancreatic region, and celiac axis (arrows). 
Figure 12. a, b. A 63-year-old female with biopsy-proven pancreatic sarcoidosis. Contrast-
enhanced CT of the abdomen (a) shows enlarged lobulated pancreas. Ill-defined multiple small 
hypodense lesions are detected in the pancreatic head and body (b, arrows).
a b
Figure 13. a–d. A 57-year-old female with biopsy-proven hepatic, splenic, and renal 
sarcoidosis. Contrast-enhanced CT of the abdomen (a, b) shows multiple hypodense 
granulomas infiltrating the liver and spleen. Small hypodense granulomas are also detected in 
both kidneys (a, b, arrows). Contour irregularity of the shrinking liver became prominent (c, 
dashed arrows) and contour irregularity of the right kidney at the site of granuloma occurred 
(d, dashed arrow) at five-month follow-up. 
c
a
d
b
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Granulomatous pseudotumors are ex-
ceedingly rare presentations of renal 
sarcoidosis with only a few patho-
logically-proven case reports (48, 
49). These pseudotumors are focal, 
exophytic nodules which may be sin-
gular or multiple, unilateral or bilat-
eral and echogenic on US (42). They 
may be hypo-, iso-, or hyperdense 
on unenhanced CT relative to the 
normal renal parenchyma, and but 
are hypo-enhancing on contrast-en-
hanced CT (Fig. 13) (48–50). On MRI, 
poor circumscription of the mass or 
masses from the renal parenchyma is 
demonstrated, indicating interstitial 
infiltration. On unenhanced T1- and 
T2-weighted imaging, the pseudotu-
mor may be homogenous or slightly 
heterogenous, predominantly re-
maining isointense to the surround-
ing renal parenchyma (48–50). There 
is less early and delayed enhancement 
relative to the normal renal cortex 
following gadolinium-based intrave-
nous contrast administration (46). Al-
though renal carcinoma, metastasis, 
lymphoma, xantogranulomatous py-
elonephritis, angiomyolipoma, and 
oncocytoma are included in the dif-
ferential diagnosis of such focal renal 
lesions, the clinical history of sarcoid-
osis and involvement of other organs 
would prevent unnecessary surgical 
interventions for the diagnosis. 
Genital tract
The diagnosis of genital tract sar-
coidosis was made on surgical spec-
imens in previously reported cases. 
Uterus is the most commonly involved 
site of the female genital system (51). It 
is usually detected while investigating 
the cause of abnormal uterine bleed-
ing in patients with a previous history 
of sarcoidosis at other anatomic sites 
(52). Ovarian sarcoidosis is extremely 
rare and known to mimic ovarian ma-
lignancy with soft tissue nodules (51). 
There is no specific radiological find-
ing in the literature to describe ovarian 
sarcoidosis (51). 
Sarcoidosis involving the male re-
productive tract has rarely been re-
ported. Granulomas may be detected 
in the epididymis, testis, and prostate 
gland, in order of decreasing frequen-
cy. Spermatic cord, scrotum, and penis 
are rarely involved (53, 54). Testicular 
(Fig. 14) and extratesticular (Figs. 15, 
16) involvement need to be differ-
entiated from other granulomatous 
diseases such as tuberculosis, syphi-
lis, Wegener’s granulomatosis, gran-
uloma inguinale, lymphogranuloma 
venereum, filariasis, coccidioidomy-
cosis, blastomycosis, actinomycosis, 
and schistosomiasis (55). The lesions 
are hypoechoic on US and generally 
hypointense on T2-weighted images. 
They exhibit enhancement on gado-
linium-enhanced T1-weighted images 
(56). Open testicular biopsy needs to be 
performed to exclude malignancy, on 
account of coexisting testicular tumors 
reported with sarcoidosis (57–59).
Conclusion
Sarcoidosis is a multisystemic in-
flammatory disease which has been 
reported in every system and organ of 
the human body. Abdominal sarcoid-
osis is less common and most often as-
ymptomatic. It may mimic more com-
mon infectious diseases or neoplasms. 
Awareness of the imaging findings of 
intra-abdominal sarcoidosis would 
help to prevent long-standing unrec-
ognized disease. 
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